- Home
- ALT vs MOV Comparison
ALT vs MOV Comparison
Compare ALT & MOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALT
- MOV
- Stock Information
- Founded
- ALT 1997
- MOV 1961
- Country
- ALT United States
- MOV United States
- Employees
- ALT N/A
- MOV N/A
- Industry
- ALT Biotechnology: Pharmaceutical Preparations
- MOV Consumer Specialties
- Sector
- ALT Health Care
- MOV Consumer Discretionary
- Exchange
- ALT Nasdaq
- MOV Nasdaq
- Market Cap
- ALT 397.4M
- MOV 339.1M
- IPO Year
- ALT N/A
- MOV 1993
- Fundamental
- Price
- ALT $4.19
- MOV $16.87
- Analyst Decision
- ALT Strong Buy
- MOV Strong Buy
- Analyst Count
- ALT 6
- MOV 1
- Target Price
- ALT $18.20
- MOV $31.50
- AVG Volume (30 Days)
- ALT 11.7M
- MOV 175.2K
- Earning Date
- ALT 08-07-2025
- MOV 09-04-2025
- Dividend Yield
- ALT N/A
- MOV 8.33%
- EPS Growth
- ALT N/A
- MOV N/A
- EPS
- ALT N/A
- MOV 0.78
- Revenue
- ALT $20,000.00
- MOV $650,768,000.00
- Revenue This Year
- ALT N/A
- MOV $0.71
- Revenue Next Year
- ALT $1,557,547.90
- MOV N/A
- P/E Ratio
- ALT N/A
- MOV $21.59
- Revenue Growth
- ALT N/A
- MOV N/A
- 52 Week Low
- ALT $2.90
- MOV $12.85
- 52 Week High
- ALT $11.16
- MOV $26.59
- Technical
- Relative Strength Index (RSI)
- ALT 39.67
- MOV 62.33
- Support Level
- ALT $4.33
- MOV $16.02
- Resistance Level
- ALT $4.79
- MOV $17.10
- Average True Range (ATR)
- ALT 0.52
- MOV 0.45
- MACD
- ALT -0.16
- MOV 0.17
- Stochastic Oscillator
- ALT 26.92
- MOV 90.38
About ALT Altimmune Inc.
Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.
About MOV Movado Group Inc.
Movado Group Inc designs, develops, sources, markets, and distributes fine watches in the United States and internationally. It operates through the Watch and Accessory Brands and Company Stores segment. The Watch and Accessory Brands segment includes the designing, manufacturing, and distribution of watches and, to a lesser extent, jewelry and other accessories of quality owned brands and licensed brands. Its Company Stores segment includes the company's retail outlet locations in the United States and Canada. It generates maximum revenue from the Watch and Accessory Brands segment. Geographically, it derives the majority of its revenue from its international locations.